It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for 10x Genomics Inc (TXG) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.48, or 1.11%, to $43.90. The 10x Genomics Inc has recorded 77,212 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that 10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies.
10x Genomics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Health Information Services industry. At the end of the last regular session, the stock closed at $43.42 and fluctuated between $44.10 as its day high and $42.00 as its day low. The current market capitalization of 10x Genomics Inc is $5.13B. A total of 1.34 million shares were traded on the day, compared to an average of 984.81K shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, TXG has seen 0 BUY and 7 SELL insider trades, representing the acquisition of 0 and the disposition of 23,750 shares. Over the last 12 months, there were 17 BUYs and 53 SELLs from insiders. Insiders purchased 403,531 shares during that period but sold 160,867.
In the most recent transaction, Saxonov Serge sold 2,000 shares of TXG for 39.52 per share on Nov 14. After the transaction, the Chief Executive Officer now owns 854,926 company shares. In a previous transaction on Oct 17, Saxonov Serge sold 1,979 shares at 39.51 per share. TXG shares that Chief Executive Officer owns now total 856,926.
Among the insiders who sold shares, Saxonov Serge disposed of 21 shares on Oct 16 at a per-share price of $39.50. This resulted in the Chief Executive Officer holding 858,905 shares of TXG after the transaction. In another insider transaction, Saxonov Serge sold 2,000 shares at $49.37 per share on Sep 14. Company shares held by the Chief Executive Officer now total 862,093.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for TXG in the last 3 months, the mean price target is $54.83 with high estimates of $70.00 and low estimates of $30.00. In terms of 52-week highs and lows, TXG has a high of $63.57 and a low of $31.28.
As of this writing, TXG has an earnings estimate of -$0.38 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of -$0.22 per share and a lower estimate of -$0.49. The company reported an EPS of -$0.53 in the last quarter, which was -32.50% lower than expectations of -$0.4.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. TXG’s latest balance sheet shows that the firm has $587.45M in Cash & Short Term Investments as of fiscal 2021. There were $81.98M in debt and $110.36M in liabilities at the time. Its Book Value Per Share was $6.30, while its Total Shareholder’s Equity was $817.57M.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TXG is Buy with a score of 4.08.